Polydiuretic Therapy for Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus
Conditions: HF - Heart Failure; Diabetes Mellitus Intervention: Drug: Bumetanide 0.5 mg, dapaglifozin 5 mg, eplerenone 25 mg Sponsor: Northwestern University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bumetanide | Cardiology | Diabetes | Diabetes Mellitus | Endocrinology | Heart | Heart Failure | Research